We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

N-Nitroso Rizatriptan

Chemical Structure
Specifications
Product name
N-Nitroso Rizatriptan
Other Name
2-(5-((1H-1,2,4-Triazol-1-yl)methyl)-1-nitroso-1H-indol-3-yl)-N,N-dimethylethan-1-amine
SRC CAT No
SRC-N014974
CAS No
NA
Mol.F.
C15H18N6O
Mol.Wt.
298.4 g/mol
Related CAS No.
NA
Inv Status
In Stock
Chemical Structure
Chemical Structure
view file icon VIEW COA

Chemical Name
2-(5-((1H-1,2,4-Triazol-1-yl)methyl)-1-nitroso-1H-indol-3-yl)-N,N-dimethylethan-1-amine

HSN Code
N.A
Synonym
N.A

Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds . Rizatriptan is used to treat the symptoms of migraine headaches (severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound and light). Rizatriptan is in a class of medications called selective serotonin receptor agonists.N-Nitroso Rizatriptan is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.

N-Nitroso Rizatriptan chemically represented as 2-(5-((1H-1,2,4-Triazol-1-yl)methyl)-1-nitroso-1H-indol-3-yl)-N,N-dimethylethan-1-amine. Synchemia is the leading manufacturing and exporter of N-Nitroso Rizatriptan.We supply N-Nitroso Rizatriptan with detailed characterization data compliance with regulatory guidelines.